Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Ocular Implants Market Grown from 2024 to 2025?
The market size for ocular implants has seen a swift expansion in the past few years. It’s projected to scale up from $14.76 billion in 2024 to $16.36 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.8%. This growth observed in the historical period can be assigned to certain factors such as ocular trauma, vision rectification, diabetic retinopathy, various eye ailments, and regulatory approvals.
What Growth Rate Is Anticipated for the Ocular Implants Market in the Coming Years?
The market size for ocular implants is projected to experience a substantial growth surge in the years to come. By 2029, it is expected to be worth $25.32 billion with a Compound Annual Growth Rate (CAGR) of 11.5%. This predicted growth in the forecast time frame can be attributed to factors such as an increasing older population, rising prevalence of myopia, management of glaucoma, minimally invasive surgical methods, and patient safety. The forecast period will also likely see major trends such as advancements in technology, innovative ophthalmic solutions, digital healthcare, regenerative medicine, and the use of artificial intelligence (AI).
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6557&type=smp
Who Are the Leading Companies in the Ocular Implants Market?
Major companies operating in the ocular implants market include Alcon Inc., Bausch & Lomb Inc., Carl Zeiss AG, STAAR Surgical Company, Johnson and Johnson Services Inc., Morcher GmbH, Aurolab Ltd., Cornea Biosciences, KERAMED INC., Price Vision Group, Gulden Ophthalmics Co. Inc., AJL Ophthalmic SA, Hoya Corp., Rayner Intraocular Lenses Limited, Lenstec Inc., SIFI S.p.A, Ophtec BV, HumanOptics AG, Medicontur Medical Engineering Ltd., Hanita Lenses, Omni Lens Pvt. Ltd., EyeKon Medical Inc., FCI Ophthalmics Inc., Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., AcuFocus Inc., Glaukos Corporation, Ivantis Inc.
What Are the Key Drivers of the Ocular Implants Market?
The global ocular implants market is anticipated to expand due to the increasing geriatric population worldwide. Those who are commonly labelled as the geriatric populace are individuals who are 65 years and above. These individuals often benefit from ocular implants, which offer remedies for frequent age-related eye issues like presbyopia, cataracts, and glaucoma. These implants enhance vision quality, decrease dependence on prescription eyewear, and enrich the seniors’ lifestyle. As per the World Health Organization, an international public health agency based in Switzerland, the global populace of individuals aged 60 years and above is predicted to reach 1.4 billion by 2022, a rise from 1 billion in 2020. Furthermore, by 2030, every sixth individual globally will be over 60 years old. Therefore, the hike in the geriatric population worldwide is expected to boost the ocular implants market’s growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=6557&type=smp
What Are the Key Market Segments in the Ocular Implants Industry?
The ocular implants market covered in this report is segmented –
1) By Product: Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants, Other Products
2) By Application: Glaucoma Surgery, Diabetic Retinopathy, Age-Related Macular Degeneration
3) By End-User: Specialty Eye Institutes, Hospitals, Clinics
Subsegments:
1) By Intraocular Lens (IOL): Monofocal IOL, Multifocal IOL, Toric IOL, Accommodative IOL
2) By Corneal Implants: Synthetic Corneal Implants, Donor Corneal Implants, Intracorneal Ring Segments (ICRS)
3) By Orbital Implants: Porous Orbital Implants, Non-Porous Orbital Implants
4) By Glaucoma Implants: Aqueous Shunts Or Valves, Micro-Invasive Glaucoma Surgery (MIGS) Devices
5) By Other Products: Scleral Buckles, Ocular Prosthesis, Retinal Implants
What Are the Latest Trends in the Ocular Implants Market?
Leading companies in the ocular implants market are concentrating their efforts on the creation of innovative solutions, such as axitinib intravitreal implants, to improve the treatment methods for eye ailments like retinal vein occlusion and diabetic macular edema. These axitinib intravitreal implants are essentially small devices capable of releasing medication, which are directly installed into the vitreous cavity of the eye, subsequently delivering axitinib—a tyrosine kinase inhibitor—in a controlled and continuous way. For instance, Ocular Therapeutix, Inc., an American pharmaceutical firm, started a key clinical trial for its axitinib intravitreal implant, named as OTX-TKI, which targets to treat wet age-related macular degeneration (wet AMD). This trial aims to scrutinize the safety and efficiency of the implant in preserving visual acuity in comparison to the conventional aflibercept treatment. The trial will be carried out as a multi-center, randomized study, with about 300 patients, aiming to evaluate OTX-TKI’s capability to deliver a consistent release of the drug, possibly minimizing the injection frequency needed for an effective treatment process.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/ocular-implants-global-market-report
What Are the Key Regional Markets in the Ocular Implants Industry?
North America was the largest region in the ocular implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ocular implants market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6557
This Report Delivers Insight On:
1. How big is the ocular implants market, and how is it changing globally?
2. Who are the major companies in the ocular implants market, and how are they performing?
3. What are the key opportunities and risks in the ocular implants market right now?
4. Which products or customer segments are growing the most in the ocular implants market?
5. What factors are helping or slowing down the growth of the ocular implants market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model